Facebook
TwitterNumber and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Facebook
TwitterAge standardized rate of cancer incidence, by selected sites of cancer and sex, three-year average, census metropolitan areas.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
The Cancer in Young People in Canada (CYP-C) program is a national, population-based surveillance system that collects health and treatment information on each child/youth under the age of fifteen diagnosed with cancer in Canada. These datasets contain the information presented in the tables and figures describing the demographics, diagnosis, treatment, location and timing of care, and outcomes in children diagnosed with cancer from 2001-2006 which were published in the following report: The Public Health Agency of Canada. (2017). Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System. Available online at https://www.canada.ca/en/health-canada/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017.html
Facebook
TwitterThe social environment represents the external conditions under which people engage in social activity within their community. It includes aspects of social opportunity, leisure and recreation, education, access to health services, health status and participation in democratic processes. Fourteen indicators have been used to assess aspects of quality of the social environment.
Facebook
TwitterThis table contains 600 series, with data for years 1997 - 1997 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (15 items: Canada; Prince Edward Island; Newfoundland and Labrador; Nova Scotia ...), Sex (3 items: Both sexes; Females; Males ...), Selected sites of cancer (ICD-9) (4 items: Colorectal cancer; Prostate cancer; Lung cancer; Female breast cancer ...), Characteristics (5 items: Relative survival rate for cancer; High 95% confidence interval; relative survival rate for cancer; Number of cases; Low 95% confidence interval; relative survival rate for cancer ...).
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
The social environment represents the external conditions under which people engage in social activity within their community. It includes aspects of social opportunity, leisure and recreation, education, access to health services, health status and participation in democratic processes. Fourteen indicators have been used to assess aspects of quality of the social environment.
Facebook
TwitterThe files included here are SAS code provided as documentation for reproducibility of results in the study titled: "Independent effects of individual- and area-level income on site-specific cancer incidence in Canada from 2006–2015: a data linkage study" by Parker Tope, Talía Malagón, Samantha Morais, Mariam El-Zein, and Eduardo L. Franco. Data Source: Statistics Canada, Canadian Census Health and Environment Cohorts 2006 & 2011, 2006 long-form census, 2011 National Household Survey, Canadian Vital Statistics Death Database 2006-2015, and Canadian Cancer Registry 2006-2015. The Postal CodeOM Conversion File Plus (7D) is based on data licensed by Canada Post Corporation. Reproduced and distributed on an "as is" basis with the permission of Statistics Canada. This does not constitute an endorsement by Statistics Canada of this product. Statistics Canada is the owner and steward of the data used in this report, and access to the data is regulated by the 1985 Statistics Act. To access the data, researchers must become deemed employees of Statistics Canada and sign a research contract. Members of post-secondary institutions such as faculty, students, or staff may apply for data access to Statistics Canada microdata through the Research Data Centre program using the Microdata Access Portal (https://www.statcan.gc.ca/en/microdata/data-centres/access).
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
This table contains 600 series, with data for years 1997 - 1997 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (15 items: Canada; Prince Edward Island; Newfoundland and Labrador; Nova Scotia ...), Sex (3 items: Both sexes; Females; Males ...), Selected sites of cancer (ICD-9) (4 items: Colorectal cancer; Prostate cancer; Lung cancer; Female breast cancer ...), Characteristics (5 items: Relative survival rate for cancer; High 95% confidence interval; relative survival rate for cancer; Number of cases; Low 95% confidence interval; relative survival rate for cancer ...).
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Facebook
TwitterThis layer utilize the 2015 boundaries of health regions in provinces and the territories of Canada. Boundaries are from Statistics Canada. Each boundary are given an incidence rate per 100,000 population taken from their data layer Cancer incidence, by selected sites of cancer and sex, three-year average, Canada, provinces, territories and health regions (2015 boundaries)
Facebook
TwitterThis table contains 30810 series, with data for years 2001/2003 - 2013/2015 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (158 items: Canada; Newfoundland and Labrador; Eastern Regional Health Authority, Newfoundland and Labrador; Central Regional Health Authority, Newfoundland and Labrador; ...); Sex (3 items: Both sexes; Males; Females); Selected sites of cancer (ICD-O-3) (5 items: All invasive primary cancer sites (including in situ bladder); Colon, rectum and rectosigmoid junction cancer; Bronchus and lung cancer; Female breast cancer; ...); Characteristics (13 items: Number of new cancer cases; Cancer incidence (rate per 100,000 population); Low 95% confidence interval, cancer incidence (rate per 100,000 population); High 95% confidence interval, cancer incidence (rate per 100,000 population); ...).
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
One woman in nine can expect to develop breast cancer during her lifetime and one in 25 will die from the disease. Statistically low incidences of breast cancer are found in Newfoundland and Labrador, the territories, and northern areas of most provinces. Otherwise, each province has one or more pockets of significantly high breast cancer incidence. These are often located in more southerly areas, but they do not seem to be restricted to either urban or rural areas alone. Breast cancer rates are a health status indicator. They can be used to help assess health conditions. Health status refers to the state of health of a person or group, and measures causes of sickness and death. It can also include people’s assessment of their own health.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
This map uses age-standardized ratios to further aid in regional comparisons. A value of 1.0 would indicate that the region rate is identical to the overall Canadian rate; a value greater than 1.0 would indicate that the rate for that region is higher than the Canadian rate; and, in turn, a ratio value less than 1.0 would indicate that the rate for the specific region is lower than the Canadian rate. Statistically low incidences of breast cancer are found in Newfoundland and Labrador, the territories, and northern areas of most provinces. Otherwise, each province has one or more pockets of significantly high breast cancer incidence. Health status refers to the state of health of a person or group, and measures causes of sickness and death. It can also include people’s assessment of their own health.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Time series data for the statistic Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%) and country Canada. Indicator Definition:Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).The indicator "Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%)" stands at 9.70 as of 12/31/2021. Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.00 percent compared to the value the year prior.The 1 year change in percent is -3.00.The 3 year change in percent is -1.02.The 5 year change in percent is -6.73.The 10 year change in percent is -11.01.The Serie's long term average value is 11.51. It's latest available value, on 12/31/2021, is 15.72 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2019, to it's latest available value, on 12/31/2021, is +1.04%.The Serie's change in percent from it's maximum value, on 12/31/2000, to it's latest available value, on 12/31/2021, is -32.64%.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
One woman in nine can expect to develop breast cancer during her lifetime and one in 25 will die from the disease. Statistically low incidences of breast cancer are found in Newfoundland and Labrador, the territories, and northern areas of most provinces. Otherwise, each province has one or more pockets of significantly high breast cancer incidence. These are often located in more southerly areas, but they do not seem to be restricted to either urban or rural areas alone. Breast cancer rates are a health status indicator. They can be used to help assess health conditions. Health status refers to the state of health of a person or group, and measures causes of sickness and death. It can also include people’s assessment of their own health.
Facebook
Twitterhttps://www.cancerimagingarchive.net/data-usage-policies-and-restrictions/https://www.cancerimagingarchive.net/data-usage-policies-and-restrictions/
The RADCURE dataset was collected clinically for radiation therapy treatment planning and retrospectively reconstructed for quantitative imaging research.
Inclusion: The dataset used for this study consists of 3,346 head and neck cancer CT image volumes collected from 2005-2017 treated with definitive RT at the University Health Network (UHN) in Toronto, Canada
Acquisition and Validation Methods: RADCURE contains computed tomography (CT) images with corresponding normal and non-normal tissue contours. CT scans were collected using systems from three different manufacturers. Standard clinical imaging protocols were followed, and contours were generated and reviewed at weekly quality assurance rounds. RADCURE imaging and structure set data was extracted from our institution’s radiation treatment planning and oncology systems using an in-house data mining and processing system. Furthermore, images are linked to clinical data for each patient and include demographic, clinical and treatment information based on the 7th edition TNM staging system. The median patient age is 63, with the final dataset including 80% males. Oropharyngeal cancer makes up 50% of the population with larynx, nasopharynx, and hypopharynx cancer, comprising 25, 12, and 5% respectively. Median follow-up was 5 years with 60% of the patients alive at last follow-up.
Data Format and Usage Notes: During extraction of images and contours from our institution’s radiation treatment planning and oncology systems, the data was converted to DICOM and RTSTRUCT formats, respectively. To improve the usability of the RTSTRUCT files, individual contour names were standardized for primary tumor volumes and 19 organs-at-risk. Demographic, clinical, and treatment information is provided as a comma-separated values (csv) file. This dataset is a superset of the Radiomic Biomarkers in Oropharyngeal Carcinoma (OPC-Radiomics) dataset and fully encapsulates all previous data; this dataset replaces the OPC-Radiomics dataset. The RTSTRUCTs from OPC-Radiomics have been standardized to adhere to the TG263 nomenclature. Age of 90 years or greater is considered PHI and set to 90 years to minimize impact to privacy. Both radiological and clinical metadata were offset by an undisclosed number of days for anonymization and should be noted for downstream analysis. The TG263-standardized RTSTRUCTs include only the GTVp (primary gross tumor volume) contours. Patients without corresponding GTVp contours will not have RTSTRUCTs.
Potential Applications: The availability of imaging, clinical, demographic and treatment data in RADCURE makes it a viable option for a variety of quantitative image analysis research initiatives. This includes the application of machine learning or artificial intelligence methods to expedite routine clinical practices, discover new non-invasive biomarkers, or develop prognostic models.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
This table contains 47094 series, with data for years 2001 - 2001 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (167 items: Canada; Newfoundland and Labrador; Health and Community Services Eastern Region; Newfoundland and Labrador; Health and Community Services St. John's Region; Newfoundland and Labrador ...), Sex (3 items: Both sexes; Males; Females ...), Selected causes of death (ICD-10) (17 items: Total; all causes of death; All malignant neoplasms (cancers);Lung cancer; Colorectal cancer ...), Characteristics (6 items: Low 95% confidence interval; number of potential years of life lost; Potential years of life lost; High 95% confidence interval; number of potential years of life lost; Number of potential years of life lost ...).
Facebook
TwitterAnnual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
This table contains 30810 series, with data for years 2001/2003 - 2013/2015 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (158 items: Canada; Newfoundland and Labrador; Eastern Regional Health Authority, Newfoundland and Labrador; Central Regional Health Authority, Newfoundland and Labrador; ...); Sex (3 items: Both sexes; Males; Females); Selected sites of cancer (ICD-O-3) (5 items: All invasive primary cancer sites (including in situ bladder); Colon, rectum and rectosigmoid junction cancer; Bronchus and lung cancer; Female breast cancer; ...); Characteristics (13 items: Number of new cancer cases; Cancer incidence (rate per 100,000 population); Low 95% confidence interval, cancer incidence (rate per 100,000 population); High 95% confidence interval, cancer incidence (rate per 100,000 population); ...).
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
To evaluate the prevalence of comorbid chronic conditions among Canadian adults with cancer and the impact of socioeconomic background on the distribution of these conditions. Canadian Community Health Survey (CCHS) 2017–2018 dataset was accessed and individuals with complete information about cancer history were reviewed. The prevalence of the following 10 chronic conditions was reviewed: asthma, chronic obstructive pulmonary disease, arthritis, hypertension, hypercholesterolemia/hyperlipidemia, heart disease, stroke, diabetes, mood disorder, and anxiety disorder. Stratification of the prevalence was done according to age, sex, and racial subgroups. Multivariable logistic regression analysis was done to evaluate the association between sociodemographic characteristics and having multiple comorbid conditions. A total of 104,362 participants were included in the current study (including 10,782 participants with a history of cancer; and 93,580 participants without a history of cancer). Among all age, sex, and race strata, participants with a history of cancer were more likely to have multiple chronic conditions (p
Facebook
TwitterNumber and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.